HHH vs UTHR · P/E 11, rev $1.47B vs P/E 20, rev $1.56B
Howard Hughes Corporation (HHH) versus United Therapeutics Corporation (UTHR) — a side-by-side from cached financials, not a winner call.
Howard Hughes Corporation (HHH) is a real estate - diversified company listed on US.
United Therapeutics Corporation (UTHR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported HHH revenue for 2025-12-31 was $1.47B. Net income was $123.9M. Revenue was up 49.9% from 2024-12-31 to 2025-12-31. HHH currently screens at market cap $4.22B and trailing P/E 11.2.
Latest reported UTHR revenue for 2026-06-30 was $1.56B. Net income was $607.9M. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
HHH currently screens at market cap $4.22B and trailing P/E 11.2. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
Not investment advice. Open the HHH and UTHR stock pages for the full models.
Not investment advice.